Edgewell Sells Feminine Care Business for $340 Million
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 6d ago
0mins
Should l Buy EPC?
Source: PRnewswire
- Transaction Completion: Edgewell Personal Care Company has completed the sale of its feminine care business to Sweden's Essity for $340 million, providing funds to strengthen its balance sheet and pay down its U.S. revolving credit facility.
- Strategic Transformation: CEO Rod Little stated that this sale is a pivotal step in Edgewell's transformation, as it simplifies the product portfolio and focuses on core businesses like shaving, sun, and skin care, enhancing the company's agility and competitiveness.
- Transition Services Agreement: Edgewell has entered into a Transition Services Agreement with Essity to provide support in areas such as accounting and IT for at least one year, ensuring a smooth transition for employees and customers of the feminine care business.
- Financial Transparency: The company plans to provide unaudited financial information related to the sale of the feminine care business to investors by February 6, 2026, further enhancing investor understanding of the company's future financial outlook.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EPC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EPC
Wall Street analysts forecast EPC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EPC is 23.60 USD with a low forecast of 19.00 USD and a high forecast of 32.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 20.750
Low
19.00
Averages
23.60
High
32.00
Current: 20.750
Low
19.00
Averages
23.60
High
32.00
About EPC
Edgewell Personal Care Company is a manufacturer and marketer of personal care products. With operations in approximately 20 countries, its products are widely available in more than 50 countries. The Company has three segments: Wet Shave, Sun and Skin Care, and Feminine Care. The Wet Shave segment consists of products sold under the Schick, Wilkinson Sword, Edge, Skintimate, Billie, Shave Guard and its custom brands group, as well as non-branded products. The Company’s Wet Shave products include razor handles and refillable blades, disposable shave products, and shaving gels and creams. The Sun and Skin Care segment products are sold under the Banana Boat, Hawaiian Tropic, Bulldog, Jack Black, Cremo and Wet Ones brand names. Feminine Care markets products under the Playtex, Stayfree, Carefree and o.b. brands. It offers tampons under the Playtex Gentle Glide 360, Playtex Sport, Playtex and o.b. brands. It also markets pads and liners under the Stayfree and Carefree brands.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Edgewell (EPC) Q1 2026 Earnings Call Transcript
See More
Edgewell Declares Quarterly Dividend of $0.15 per Share
- Quarterly Dividend Declaration: Edgewell has declared a quarterly dividend of $0.15 per share, consistent with previous distributions, demonstrating the company's ongoing ability to maintain stable cash flow, which is likely to attract income-seeking investors.
- Dividend Yield: The forward yield of 2.89% reflects the company's attractiveness in the current market environment, potentially increasing investor interest in Edgewell's stock.
- Dividend Payment Dates: The dividend is payable on April 8, with a record date of March 6 and an ex-dividend date also on March 6, providing investors with a clear timeline for their investment decisions.
- Future Outlook: Edgewell's FY26 outlook projects organic net sales growth targets ranging from a decline of 1% to an increase of 2%, indicating a cautious approach in the face of market challenges while divesting feminine care products to optimize its business structure.
See More
Edgewell Q1 Earnings Beat Expectations, Cautious Outlook Ahead
- Earnings Beat: Edgewell reported Q1 non-GAAP EPS of $0.03, exceeding expectations by $0.19, with revenue of $486.8 million reflecting a 1.8% year-over-year increase, surpassing estimates by $9.12 million, indicating resilience in a challenging market.
- Core Operations Performance: Continuing operations, excluding the Feminine Care business, generated net sales of $422.8 million, up 1.9% year-over-year, although organic net sales fell by 0.5%, highlighting external market pressures impacting sales.
- Cautious Outlook: The company expects reported net sales to grow between 0.5% and 3.5%, with organic net sales anticipated to range from a 1% decline to a 2% increase, reflecting uncertainty in future market conditions, particularly post-divestiture of the Feminine Care segment.
- Financial Metrics Adjustments: GAAP EPS is projected between $0.55 and $0.95, while adjusted EPS is expected to range from $1.70 to $2.10, reflecting significant impacts from the Feminine Care divestiture, with adjusted EBITDA forecasted between $245 million and $265 million, indicating challenges in cost management.
See More
Edgewell Exceeds Q1 Expectations with Strategic Divestiture
- Performance Exceeds Expectations: Edgewell reported net sales of $422.8 million for Q1 2026, reflecting a 1.9% increase, bolstered by a favorable currency impact of $9.6 million, demonstrating strong execution in core business areas.
- Strategic Divestiture: The successful divestiture of the Feminine Care business for $340 million not only sharpens the company's portfolio focus but also strengthens its balance sheet, laying a solid foundation for future sustainable growth.
- Adjusted Financial Outlook: After adjusting for the divestiture's impact, Edgewell's full-year outlook for continuing operations remains unchanged, with expectations for sales, adjusted EPS, and free cash flow consistent with prior forecasts, indicating stability during the transformation process.
- Cost Efficiency Improvements: The company recorded $24.4 million in restructuring charges in Q1, aimed at enhancing operational efficiency and effectiveness, which is expected to positively influence future financial performance.
See More
Edgewell Sells Feminine Care Business for $340 Million
- Transaction Completion: Edgewell Personal Care Company has completed the sale of its feminine care business to Sweden's Essity for $340 million, providing funds to strengthen its balance sheet and pay down its U.S. revolving credit facility.
- Strategic Transformation: CEO Rod Little stated that this sale is a pivotal step in Edgewell's transformation, as it simplifies the product portfolio and focuses on core businesses like shaving, sun, and skin care, enhancing the company's agility and competitiveness.
- Transition Services Agreement: Edgewell has entered into a Transition Services Agreement with Essity to provide support in areas such as accounting and IT for at least one year, ensuring a smooth transition for employees and customers of the feminine care business.
- Financial Transparency: The company plans to provide unaudited financial information related to the sale of the feminine care business to investors by February 6, 2026, further enhancing investor understanding of the company's future financial outlook.
See More
Edgewell Sells Feminine Care Business for $340 Million
- Transaction Value: Edgewell has sold its feminine care business to Sweden's Essity for $340 million, which will provide significant funding to strengthen its balance sheet and pay down the balance of its U.S. revolving credit facility.
- Strategic Transformation: CEO Rod Little emphasized that this sale is a pivotal step in Edgewell's transformation, as it simplifies the product portfolio and focuses resources on core areas like shaving, sun, and skin care, enhancing the company's agility and competitiveness.
- Transition Services Agreement: Edgewell has entered into a Transition Services Agreement with Essity to provide support in areas such as accounting and IT for at least one year, ensuring a smooth transition for employees, customers, and consumers of the feminine care business.
- Financial Transparency: The company plans to provide unaudited financial information related to the sale by February 6, 2026, enhancing transparency and trust in its future financial reporting to investors.
See More
Edgewell (EPC) Q1 2026 Earnings Call Transcript
See More
Edgewell Declares Quarterly Dividend of $0.15 per Share
- Quarterly Dividend Declaration: Edgewell has declared a quarterly dividend of $0.15 per share, consistent with previous distributions, demonstrating the company's ongoing ability to maintain stable cash flow, which is likely to attract income-seeking investors.
- Dividend Yield: The forward yield of 2.89% reflects the company's attractiveness in the current market environment, potentially increasing investor interest in Edgewell's stock.
- Dividend Payment Dates: The dividend is payable on April 8, with a record date of March 6 and an ex-dividend date also on March 6, providing investors with a clear timeline for their investment decisions.
- Future Outlook: Edgewell's FY26 outlook projects organic net sales growth targets ranging from a decline of 1% to an increase of 2%, indicating a cautious approach in the face of market challenges while divesting feminine care products to optimize its business structure.
See More
Edgewell Q1 Earnings Beat Expectations, Cautious Outlook Ahead
- Earnings Beat: Edgewell reported Q1 non-GAAP EPS of $0.03, exceeding expectations by $0.19, with revenue of $486.8 million reflecting a 1.8% year-over-year increase, surpassing estimates by $9.12 million, indicating resilience in a challenging market.
- Core Operations Performance: Continuing operations, excluding the Feminine Care business, generated net sales of $422.8 million, up 1.9% year-over-year, although organic net sales fell by 0.5%, highlighting external market pressures impacting sales.
- Cautious Outlook: The company expects reported net sales to grow between 0.5% and 3.5%, with organic net sales anticipated to range from a 1% decline to a 2% increase, reflecting uncertainty in future market conditions, particularly post-divestiture of the Feminine Care segment.
- Financial Metrics Adjustments: GAAP EPS is projected between $0.55 and $0.95, while adjusted EPS is expected to range from $1.70 to $2.10, reflecting significant impacts from the Feminine Care divestiture, with adjusted EBITDA forecasted between $245 million and $265 million, indicating challenges in cost management.
See More
Edgewell Exceeds Q1 Expectations with Strategic Divestiture
- Performance Exceeds Expectations: Edgewell reported net sales of $422.8 million for Q1 2026, reflecting a 1.9% increase, bolstered by a favorable currency impact of $9.6 million, demonstrating strong execution in core business areas.
- Strategic Divestiture: The successful divestiture of the Feminine Care business for $340 million not only sharpens the company's portfolio focus but also strengthens its balance sheet, laying a solid foundation for future sustainable growth.
- Adjusted Financial Outlook: After adjusting for the divestiture's impact, Edgewell's full-year outlook for continuing operations remains unchanged, with expectations for sales, adjusted EPS, and free cash flow consistent with prior forecasts, indicating stability during the transformation process.
- Cost Efficiency Improvements: The company recorded $24.4 million in restructuring charges in Q1, aimed at enhancing operational efficiency and effectiveness, which is expected to positively influence future financial performance.
See More
Edgewell Sells Feminine Care Business for $340 Million
- Transaction Completion: Edgewell Personal Care Company has completed the sale of its feminine care business to Sweden's Essity for $340 million, providing funds to strengthen its balance sheet and pay down its U.S. revolving credit facility.
- Strategic Transformation: CEO Rod Little stated that this sale is a pivotal step in Edgewell's transformation, as it simplifies the product portfolio and focuses on core businesses like shaving, sun, and skin care, enhancing the company's agility and competitiveness.
- Transition Services Agreement: Edgewell has entered into a Transition Services Agreement with Essity to provide support in areas such as accounting and IT for at least one year, ensuring a smooth transition for employees and customers of the feminine care business.
- Financial Transparency: The company plans to provide unaudited financial information related to the sale of the feminine care business to investors by February 6, 2026, further enhancing investor understanding of the company's future financial outlook.
See More
Edgewell Sells Feminine Care Business for $340 Million
- Transaction Value: Edgewell has sold its feminine care business to Sweden's Essity for $340 million, which will provide significant funding to strengthen its balance sheet and pay down the balance of its U.S. revolving credit facility.
- Strategic Transformation: CEO Rod Little emphasized that this sale is a pivotal step in Edgewell's transformation, as it simplifies the product portfolio and focuses resources on core areas like shaving, sun, and skin care, enhancing the company's agility and competitiveness.
- Transition Services Agreement: Edgewell has entered into a Transition Services Agreement with Essity to provide support in areas such as accounting and IT for at least one year, ensuring a smooth transition for employees, customers, and consumers of the feminine care business.
- Financial Transparency: The company plans to provide unaudited financial information related to the sale by February 6, 2026, enhancing transparency and trust in its future financial reporting to investors.
See More
